Never Gonna Give You Up – Current Developments in Covalent Protein Kinase Inhibitors

Covalent inhibitors have recently seen a revival in medicinal chemistry. Inhibitors addressing non-catalytic cysteine residues with weakly reactive electrophiles have been very successfully employed to target protein kinases, one of the major druggable protein families. Here we provide an overview...

Full description

Bibliographic Details
Main Authors: Laura Hillebrand, Matthias Gehringer
Format: Article
Language:deu
Published: Swiss Chemical Society 2022-05-01
Series:CHIMIA
Subjects:
Online Access:https://chimia.ch/chimia/article/view/6037
Description
Summary:Covalent inhibitors have recently seen a revival in medicinal chemistry. Inhibitors addressing non-catalytic cysteine residues with weakly reactive electrophiles have been very successfully employed to target protein kinases, one of the major druggable protein families. Here we provide an overview of irreversible and reversible covalent protein kinase inhibitors in clinical development and beyond. We further spotlight recent advances in targeting amino acids other than cysteine and the reactive groups utilized in covalent protein kinase inhibitors.
ISSN:0009-4293
2673-2424